金城医药(300233.SZ)：吗啉硝唑氯化钠注射液收到药品注册证书

Core Viewpoint - Jincheng Pharmaceutical has received a drug registration certificate from the National Medical Products Administration for its product, Morinazole Sodium Chloride Injection, which is a new antibacterial drug with lower adverse reaction rates and broader applications in treating various infections [1] Group 1: Product Details - Morinazole is a 5-nitroimidazole class antibacterial drug that improves stability by replacing the unstable chloride ion in ornidazole with a more stable morpholine ring [1] - The drug is indicated for adult infections caused by sensitive bacteria, including gynecological pelvic inflammatory diseases and mixed infections of appendicitis [1] Group 2: Indications - The product is suitable for treating pelvic inflammatory diseases caused by bacteria such as Streptococcus, Bacteroides, and Clostridium [1] - It also addresses purulent appendicitis and necrotizing appendicitis caused by anaerobic and aerobic bacteria [1]